Coronary Stent Market Share, Size, Trends, Industry Analysis Report, By Product (Drug Eluting Stents, Bioresorbable Vascular Scaffold Stents, Bare Metal Stents); By Metal; By Biomaterial; By End-Use; By Region; Segment Forecast, 2023 - 2032

Coronary Stent Market Share, Size, Trends, Industry Analysis Report, By Product (Drug Eluting Stents, Bioresorbable Vascular Scaffold Stents, Bare Metal Stents); By Metal; By Biomaterial; By End-Use; By Region; Segment Forecast, 2023 - 2032

The global coronary stent market size is expected to reach USD 12,248.80 million by 2032, according to a new study by Polaris Market Research. The report “Coronary Stent Market Share, Size, Trends, Industry Analysis Report, By Product (Drug Eluting Stents, Bioresorbable Vascular Scaffold Stents, Bare Metal Stents); By Metal; By Biomaterial; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The coronary stent market refers to the demand for medical devices known as coronary stents, which treat coronary artery disease (CAD). This disease is when the arteries that provide blood to the heart become narrowed or blocked due to plaque buildup.

Coronary stents are minor, mesh-like tubes implanted into blocked or narrowed coronary arteries during percutaneous coronary intervention (PCI) or angioplasty. The stent helps to open up the blocked artery and restore blood stream to the heart muscle.

The coronary stent market encompasses the manufacturing, distributing, and selling of various types of stents, including bare-metal stents, drug-eluting stents, and bioresorbable stents. These stents may differ in their composition, design, and the presence of drugs that help prevent the reoccurrence of blockages.

The increasing prevalence of coronary artery disease, the growing aging population, lifestyle changes, and advancements in stent technology drive the market. Factors like improving healthcare infrastructure, rising awareness about cardiovascular diseases, and access to minimally invasive procedures contribute to market growth.

The coronary stent market is competitive and includes several major players: multinational corporations and smaller regional manufacturers. These companies engage in research and development activities to introduce innovative stent designs and materials that offer improved performance and patient outcomes.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective coronary stent devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for coronary stents throughout the forecast period.

Coronary Stent Market Report Highlights

In 2022, the Drug-Eluting Stents (DES) segment held the largest revenue share in the Coronary Stent Market due to continuous advancements, and the introduction of new devices has strengthened the position of DES as the preferred choice for percutaneous coronary intervention (PCI) procedures.

The hospital segment accounted for the highest market share during the forecast period. The hospitals have state-of-the-art facilities and specialized medical personnel, making them the preferred choice for critical cardiac surgeries and procedures such as percutaneous coronary intervention (PCI). Hospitals often have established referral networks and receive more patients, further boosting their market share.

In 2022, North America dominated the largest market due to the high prevalence of cardiovascular diseases, including coronary artery disease, which drives the demand for coronary stents. Additionally, the region has a well-established healthcare infrastructure and advanced medical technologies, allowing for the widespread adoption and utilization of coronary stents.

The Asia-Pacific region accounted for the fastest growth in the Coronary Stent Market due to local vendors' active development of technologically advanced and competitively priced coronary stents. It focuses on addressing the market's needs that have contributed to increased market share. The availability of high-quality and affordable stents from local vendors has been a key driver of growth in the region.

The global key market players include Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group (acquired by Blue Sail Medical Co., Ltd), Biotronik SE & Co.KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medicals, Lepu Medicals, Liaoning Biomedical Materials, Medtronic Plc, Meril Life Sciences, MicroPort Scientific Corporation, Shandong JW Medical Systems, Stentys SA, Terumo Corporation, Translumina GmbH, Vascular Concepts.

Polaris Market Research has segmented the coronary stent market report based on product, metal, biomaterial, end-use, and region:

Coronary Stent, Product Outlook (Revenue - USD Million, 2019 - 2032)

Drug Eluting Stents

Biodegradable

Non-Biodegradable

Bioresorbable Vascular Scaffold Stents

Bare Metal Stents

Covered Stents

Others

Coronary Stent, Metal Outlook (Revenue - USD Million, 2019 - 2032)

Cobalt Chromium

Platinum Chromium

Nickel Titanium

Stainless Steel

Coronary Stent, Biomaterial Outlook (Revenue - USD Million, 2019 - 2032)

Metallic biomaterials

Polymers biomaterials

Natural biomaterials

Coronary Stent, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals

Ambulatory Surgical Centers

Cardiology Centers

Specialty Clinics

Others

Coronary Stent, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa